# POEMS Syndrome Treatment With Lenalidomide

> **NCT01639898** · PHASE2 · COMPLETED · sponsor: **University Hospital, Limoges** · enrollment: 51 (actual)

## Conditions studied

- POEMS Syndrome

## Interventions

- **DRUG:** Lenalidomide and dexamethasone
- **DRUG:** Lenalidomide and dexamethasone

## Key facts

- **NCT ID:** NCT01639898
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2018-06
- **Final completion:** 2018-07
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2019-07-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01639898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01639898, "POEMS Syndrome Treatment With Lenalidomide". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01639898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*